Profitability
Weight: 25%
D-
30
- 5yr Avg ROIC -11.5%
- Operating Margin Trend +94.79 pp/yr
AUPH
Aurinia Pharmaceuticals Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
⚠ 3 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a platform & compounding fcf business.
Grade overrides the 30.0 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
6
- 5yr Avg ROE -6.8%
- 5yr Share-Count CAGR 3.2%
Growth Quality
Weight: 25%
A+
94
- 5yr Revenue CAGR 41.4%
- Revenue-Growth Years (5) 4/5
Cash Generation
Weight: 20%
D-
29
- 5yr FCF Margin -72.3%
- 5yr FCF/NI Conversion 4.07x
Balance Sheet
Weight: 10%
A+
100
- Net Debt / EBITDA -2.53x
- Interest Coverage (EBIT/Int) 27.36x
- Altman Z-Score 7.61
Stability
Weight: 5%
B
73
- Negative-Revenue Years (5) 1/5
- Piotroski F-Score 6
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.2 of 2 gurus held; 2 trimmed.
- Holders
- 2
- Avg Δ position
- -17.2%
- New buys
- 0
- Full exits
- 0
- Greenblatt decreased -24%
- Cooperman decreased -10%